Medicinal Cannabis Is Now Listed In The Pharmaceutical Benefits Scheme

This year’s federal budget announcement has come with a major and welcome surprise for chronic pain sufferers — the inclusion of a new medicinal cannabis product subsidised by the Pharmaceutical Benefits Scheme (PBS). So far, the cannabidiol Epidyolex is only approved for treatment of Dravet syndrome, a rare genetic disorder which causes drug-resistant epilepsy, but there’s […]